Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
101BHG-D01 Nasal Spray in Chronic Rhinitis (Phase Ib/IIa)
CTR20212711Phase 2Completed
- Sponsor
- Beijing Shuobai Pharmaceutical Technology
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shubaile in chronic rhinitis, sponsored by Beijing Shuobai Pharmaceutical Technology. Started Nov 2021; status: completed.
02
Drugs
Shubaile
03
Conditions
chronic rhinitis
Beyond the preview
Go deeper on CTR20212711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212711.